Biomarker Changes in Relapsing Multiple Sclerosis (RMS) patients after B cell Depletion with Ocrelizumab
A. H. Cross,C. T. Harp,J. L. Bennett,H. C. von Budingen, R. Carruthers, K. Edwards,E. Eggers, R. Fallis,D. Fiore,J. M. Gelfand,P. S. Giacomini,B. M. Greenberg,D. A. Hafler,E. E. Longbrake, B. Assman, C. Ionete,U. W. Kaunzner,C. Lock,X. Ma, B. Musch,G. Pardo,F. Piehl, M. S. Weber,T. Ziemssen, A. E. Herman, A. Bar-Or MULTIPLE SCLEROSIS JOURNAL（2020）
AI 理解论文
溯源树
样例
